Skip to main content
. 2020 Mar 10;10:4429. doi: 10.1038/s41598-020-61370-y

Figure 2.

Figure 2

N-glycosylation at the N-terminal region is required for the optimal expression of Gpr176. (A) Gpr176 is N-glycosylated in Flp-In TREx293 cells. Dox-treated Flp-In TREx293-Gpr176 (tet-on) cell extracts were treated with PNGase F or O-glyc and immunoblotted for Gpr176 (upper) and β-Actin (lower). (B) Immunoblots of Dox-treated (+) and untreated (−) Flp-In TREx293 (tet-on) cells expressing WT Gpr176 and the respective mutants for potential N-linked glycosylation sites: N-ter (N4, 11, 17, 26Q), ECL3 (N295Q), and N-ter/ECL3 (N4, 11, 17, 26, 295Q). The same membrane exposed for a longer time is shown on the right. A closed arrowhead indicates the position of the proteins with an N-ter mutation. An open arrowhead points to a minor fraction of Dox-induced WT proteins. Asterisk, nonspecific bands. (C,D) Dox-induced mRNA (C) and protein (D) expression levels of WT Gpr176 and the N-ter, ECL3, and N-ter/ECL3 Gpr176 mutants. Relative Gpr176 mRNA levels were determined by qRT-PCR and normalized to the expression levels of the gene encoding the ribosomal phosphoprotein P0. Values are the means ± s.d. (n = 4). For protein levels, relative band intensities in blots exposed for a longer time (B) were determined using densitometry. ***P < 0.0001 versus WT, one-way ANOVA with Bonferroni post hoc test. Values are the means ± s.d. (n = 3).